Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-25-000834
Filing Date
2025-05-13
Accepted
2025-05-13 16:05:36
Documents
55
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bdpt_10q.htm   iXBRL 10-Q 607499
2 CERTIFICATION bdpt_ex311.htm EX-31.1 9667
3 CERTIFICATION bdpt_ex312.htm EX-31.2 8252
4 CERTIFICATION bdpt_ex321.htm EX-32.1 3691
5 CERTIFICATION bdpt_ex322.htm EX-31.2 3458
11 bdpt_10qimg2.jpg GRAPHIC 3832
  Complete submission text file 0001640334-25-000834.txt   3038972

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bdpt-20250331.xsd EX-101.SCH 31153
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdpt-20250331_lab.xml EX-101.LAB 179229
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdpt-20250331_cal.xml EX-101.CAL 33711
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdpt-20250331_pre.xml EX-101.PRE 153474
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdpt-20250331_def.xml EX-101.DEF 88800
58 EXTRACTED XBRL INSTANCE DOCUMENT bdpt_10q_htm.xml XML 386448
Mailing Address 2620 REGATTA DRIVE SUITE 102 LAS VEGAS NV 89128
Business Address 2620 REGATTA DRIVE SUITE 102 LAS VEGAS NV 89128 (702) 659-8829
BIOADAPTIVES, INC. (Filer) CIK: 0001575142 (see all company filings)

EIN.: 462592228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54949 | Film No.: 25939973
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)